Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Cardiovascular Research and Technology

Published by: IncreMental Advantage

Published: Dec. 15, 2007 - 53 Pages


Table of Contents



I. Report Introduction: Robert LeBoyer, Analyst/Interviewer

II. Richard Lundsford, President and CEO, Acorn Cardiovascular

III. Jerry Wisler, President and CEO, Aegerion Pharmaceuticals, Inc.

IV. Andrew Pecora, MD, FACP, Amorcyte

V. Paul J. Southworth, President and CEO, CircuLite, Inc.

VI. Cesar M. Diaz, Chairman and CEO, Cardiac Output Technologies, Inc.,

VII. Marvin l. Woodall, CEO, Cardiac Research Foundation

VIII. Richard Linder, President and CEO, Coherex Medical Inc.

IX. Brian D. Rye, CFA, Janney Montgomery Scott LLC

X. Clyde Baker, President and CEO, On-X Life Technologies, Inc.

XI. Samuel M. Shaolian, President, MiCardia Corporation

XII. David Blaszczak, Senior Vice President and Medical Technology Analyst, Stanford Financial Group

XIII. Don Margolis, Founder and President, TheraVitae

Abstract

In this special report, IncreMental Advantage profiles several companies focused on developing new therapies in the field of cardiovascular research. Products in development range from devices to assist in regulating the heart rhythm to replacing cells lost to heart disease. Some companies are developing devices that improve on the current treatments with new technologies, while others have unique devices which, at the current time, have no known marketed counterparts.

This report features interviews with multiple authorities in the biotechnology industry and cardiovascular research. Interviewees include:
  • Richard Linder, President and CEO, Coherex Medical Inc.
  • Cesar Diaz, Chairman and CEO, Cardiac Output Technologies
  • David Blasczak, Senior V.P and Analyst, Stanford Financial Group
  • Marvin Woodall, CEO, Cardiac Research Foundation
  • Richard Lundsford, President and CEO, Acorn Cardiovascular
Topics include:
  • Adult stem cell use
  • Cellular therapy
  • Changes in government regulations and policies
  • Techniques for closing patent foramen ovale
  • Addressing problems associated with traditional mechanical valves
  • Methods to reduce the need for invasive surgeries


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008